HIV news from aidsmap.com

Dual immune modulators delay, but don’t prevent, HIV rebound after stopping antiretrovirals
A pair of immune-modulating drugs, budigalimab and trosunilimab, appeared to slow viral rebound in about a quarter of people with HIV who stopped antiretroviral therapy (ART), according to study results presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver. Some participants eventually saw their viral load rise with further follow-up, however, and development of this combination will not continue.
>> Read more

Oropharyngeal cancer is becoming more common in heterosexual men with HIV
Cancer in the back of the mouth or throat (oropharyngeal cancer) is no longer a rare cancer in some groups of people with HIV, especially heterosexual men, a large North American study reported at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, US on Monday.
>> Read more

Statin treatment reduces blood pressure in people with HIV, REPRIEVE trial shows
Developing high blood pressure doubled the risk of experiencing a cardiovascular event, such as a stroke or heart attack, in the REPRIEVE study of statin treatment in people with HIV, and being assigned to pitavastatin significantly reduced the risk of developing high blood pressure, study investigators reported at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver on Monday.
>> Read more